Showing results (481-490 of 498) with videos related to
Sort By:
Pageof 50
Proteomics. Clinical Applications|June 10, 2011
A database of reaction monitoring mass spectrometry assays for elucidating therapeutic response in cancerElizabeth R Remily-Wood, Richard Z Liu, Yun Xiang, et al.The Journal of Clinical Investigation|September 28, 2018
PLK1 stabilizes a MYC-dependent kinase network in aggressive B cell lymphomasYuan Ren, Chengfeng Bi, Xiaohong Zhao, et al.Nature Communications|April 19, 2017
Unification of de novo and acquired ibrutinib resistance in mantle cell lymphomaXiaohong Zhao, Tint Lwin, Ariosto Silva, et al.American Journal of Human Genetics|June 20, 2017
Mutations in ARMC9, which Encodes a Basal Body Protein, Cause Joubert Syndrome in Humans and Ciliopathy Phenotypes in ZebrafishJulie C Van De Weghe, Tamara D S Rusterholz, Brooke Latour, et al.Journal of Medical Genetics|June 21, 2015
Joubert syndrome: a model for untangling recessive disorders with extreme genetic heterogeneityR Bachmann-Gagescu, J C Dempsey, I G Phelps, et al.American Journal of Human Genetics|December 24, 2013
Mutations in CSPP1 cause primary cilia abnormalities and Joubert syndrome with or without Jeune asphyxiating thoracic dystrophyKarina Tuz, Ruxandra Bachmann-Gagescu, Diana R O'Day, et al.Blood|July 15, 2006
A randomized phase 2 study of lenalidomide therapy for patients with relapsed or relapsed and refractory multiple myelomaPaul G Richardson, Emily Blood, Constantine S Mitsiades, et al.Human Mutation|November 1, 2020
Loss of CBY1 results in a ciliopathy characterized by features of Joubert syndromeDaniel Epting, Lokuliyange D S Senaratne, Elisabeth Ott, et al.Journal of Medical Genetics|October 23, 2015
MKS1 regulates ciliary INPP5E levels in Joubert syndromeGisela G Slaats, Christine R Isabella, Hester Y Kroes, et al.Cancer Research|July 1, 1996
Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: consensus recommendationsW T Beck, T M Grogan, C L Willman, et al.Pageof 50